NVCT
Ticker
Nuvectis Pharma, Inc.
NVCT · Healthcare · Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of s…Nuvectis Pharma, Inc. (NVCT), in the Healthcare sector, has 3 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 3 purchases and 0 sales, 1 filed past the deadline. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Jun 30 and filed Jul 1. The most active filer was Marlio Charles Mosseri with 6 filings.
Add to watchlistFilings, ttm
3
3 buys · 0 sells · 1 late
Traders, ttm
2
2 insiders
Volume, ttmiDollar value disclosed in the window
$2.1M
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Jun 30
Filed Jul 1
ADViAverage daily dollar volume
$5.8M
market data
Share price · 12M
$18.96 (+194.9%)
Adjusted for splits and dividends.
Volume by month
Buys $3.9M
Sells $0
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
MM
Marlio Charles Mosseri
10% owner
6 filings
RB
Ron Bentsur
Chairman & CEO
1 filing
Recent filings
Marlio Charles MosseriPURCHASE
10% owner
$916K50,000 sh × $18.32
Exec Jun 30
Filed Jul 1 · 1:41 PM ET Ron BentsurPURCHASE Chairman & CEO $250K
12,500 sh × $20.00
Exec Jun 30
Filed Jul 1 · 1:39 PM ET Marlio Charles MosseriPURCHASE 10% owner $957K
154,770 sh across 3 lots
Exec Oct 23 2025
Filed Oct 29 2025 · 8:00 AM ET † Marlio Charles MosseriPURCHASE 10% owner $226K
28,043 sh × $8.05
Exec Jun 18 2025
Filed Jun 20 2025 · 5:30 PM ET Marlio Charles MosseriPURCHASE 10% owner $172K
21,167 sh × $8.11
Exec May 12 2025
Filed May 13 2025 · 5:30 PM ET Marlio Charles MosseriPURCHASE 10% owner $1.2M
240,000 sh × $5.00
Exec Feb 7 2025
Filed Feb 11 2025 · 5:30 PM ET Marlio Charles MosseriPURCHASE 10% owner $149K
32,121 sh × $4.64
Exec Dec 12 2024
Filed Dec 16 2024 · 5:30 PM ET